Complement Factor B Activity Assay

Creative Biolabs offers customized complement Factor B activity assay services to support researchers who need reliable, pathway-relevant, and mechanism-resolved analysis of factor B function. We help clients generate interpretable data for target validation, drug discovery, lead optimization, preclinical evaluation, and translational immunology research.

Submit Your Request Now

Download our service brochure

Inquiry

Why Complement Factor B Activity Evaluation Matters

Complement Factor B is indispensable for this alternative pathway amplification. In its native form, Factor B circulates as an inactive zymogen. When C3b is deposited on an activating surface, Factor B binds to C3b in a magnesium-dependent manner to form the C3bB proconvertase. Factor D then cleaves Factor B into Ba and Bb fragments. Bb remains associated with C3b and forms the alternative pathway C3 convertase, C3bBb. This convertase cleaves additional C3 molecules, generating more C3b and driving a positive feedback loop. When additional C3b joins the convertase complex, the pathway can progress toward C5 cleavage and terminal complement activation.

Because Factor B sits at this amplification node, even modest changes in its activity may significantly affect complement output. Excessive Factor B activity may contribute to complement-mediated inflammation, tissue injury, autoimmune pathology, renal disease, ocular disease, neuroinflammation, transplant-related injury, and other complement-associated disorders. Conversely, insufficient Factor B function may impair innate immune defense and reduce alternative pathway activity. Therefore, Factor B activity assays are essential for understanding whether a biological sample, therapeutic candidate, mutation, inhibitor, antibody, serum condition, or disease model alters the functional capacity of the alternative pathway.

Creative Biolabs designs Factor B activity assays to provide this functional perspective. Depending on the project, our scientists can evaluate Factor B at the level of cleavage, convertase assembly, enzymatic activity, pathway amplification, downstream complement fragment generation, hemolytic readout, cell-surface deposition, or inhibitor response. This flexible strategy enables clients to obtain mechanistic data rather than a single endpoint measurement.

Great Minds Choose Creative Biolabs

Partner with Us

Our Complement Factor B Activity Assay Service

Creative Biolabs provides comprehensive complement Factor B activity assay services for academic, biotechnology, pharmaceutical, diagnostic, and translational research programs.

Purified-Component Factor B Activity Assay

Purified-component assays are useful when the objective is to isolate Factor B function from the broader complexity of serum complement. This format can be used to evaluate Factor B binding to C3b, Factor D-mediated cleavage, Ba/Bb generation, C3bBb formation, convertase stability, properdin-dependent stabilization, and inhibition by candidate molecules.

Serum-Based Alternative Pathway Factor B Activity Assay

Serum-based assays provide a physiologically relevant platform for evaluating Factor B activity within the native complement environment. This format can be used to assess alternative pathway activity in human serum, animal serum, disease-model samples, donor samples, treated samples, or serum spiked with therapeutic candidates.

Bb Generation Assay

Bb generation is one of the most direct indicators of Factor B activation. Creative Biolabs offers Bb generation assays using immunoassay, plate-based detection, electrochemiluminescence, Western blot, multiplex analysis, or other detection strategies depending on sensitivity and throughput requirements.

Ba Fragment Detection Assay

Ba is the non-catalytic fragment released during Factor B cleavage. Creative Biolabs can develop or optimize Ba detection assays for serum, plasma, purified systems, culture supernatants, or biological fluids. Depending on the project objective, Ba detection can be used alone or combined with Bb, C3a, C5a, C3b, iC3b, or sC5b-9 analysis to build a broader complement activation profile.

C3 Convertase Activity Assay

Creative Biolabs can configure C3 convertase activity assays to measure C3 cleavage, C3a generation, C3b deposition, substrate turnover, convertase decay, or inhibitor-mediated suppression. Purified C3 may be used as a substrate, or serum-based systems may be used to preserve physiological pathway interactions.

Alternative Pathway Hemolytic Activity Assay

For Factor B-related projects, alternative pathway hemolytic assays can be used to assess whether Factor B activity is sufficient to support downstream complement-mediated lysis, whether a candidate inhibitor blocks functional pathway output, or whether biological samples show altered alternative pathway capacity.

Cell-Based Factor B-Dependent Complement Activity Assay

Creative Biolabs can design cell-based assays to measure C3b deposition, iC3b formation, Bb deposition, C5b-9 assembly, complement-dependent cytotoxicity, opsonization, inflammatory mediator production, or inhibitor protection.

Inhibitor Screening and Potency Assay

Factor B is an attractive target for complement therapeutic discovery because of its central role in alternative pathway amplification. Creative Biolabs provides customized inhibitor screening and potency assays to evaluate these candidates in appropriate functional systems.

Discuss Your Needs

Sample Types and Species Options

Creative Biolabs supports multiple sample types for complement Factor B activity analysis. The selection of sample type depends on the scientific question and assay format.

Human/Animal serum, plasma with suitable anticoagulant selection

Purified factor B protein, recombinant factor B variants

Biological fluids, cell culture supernatants

Complement samples, disease-model samples

Workflow of Complement Factor B Activity Assay

Creative Biolabs proposes conducting the complement FB functional assay utilizing ELISA and SPR technology.

Complement FB assay. (Creative Biolabs Original) Fig. 1 Workflow of complement factor B functional test.

Design Your Workflow

Customized Services for Different Research Goals

For Early Discovery

Creative Biolabs can provide screening-friendly assays to identify candidates that modulate Factor B activity. These assays may prioritize robustness, throughput, dynamic range, and clear ranking. Suitable readouts may include Bb generation, C3 cleavage, C3b deposition, or hemolytic inhibition.

For Lead Optimization

For lead optimization, assays can be configured to compare variants, formats, concentrations, lots, or formulations. Dose-response curves, potency estimation, serum performance, and mechanism-relevant readouts can support candidate prioritization.

For Mechanism-of-Action Studies

Mechanistic studies may require purified systems, kinetic analysis, binding-dependent assays, convertase formation assays, decay analysis, or multi-readout profiling. Creative Biolabs can help determine whether a candidate affects Factor B binding, cleavage, Bb activity, convertase stability, or downstream amplification.

For Preclinical Evaluation

Preclinical studies may require species-relevant assays, serum-based activity testing, disease-model samples, translational biomarker panels, or cell-based complement activity models. Creative Biolabs can develop assays that support preclinical decision-making and future translational planning.

Applications of Complement Factor B Activity Assay

Application	Description
Complement-Targeted Drug Discovery	Factor B activity assays can help determine whether a candidate molecule effectively blocks alternative pathway amplification, reduces convertase activity, suppresses downstream inflammatory fragments, or protects target cells from complement-mediated injury.
Factor B Inhibitor Characterization	For programs specifically targeting Factor B, functional characterization is critical. A candidate may bind Factor B but fail to prevent C3b binding. It may prevent cleavage but only at high concentrations. It may inhibit purified systems but perform differently in serum. It may block Bb generation but show limited downstream effect due to assay matrix or compensatory pathway activity.
Alternative Pathway Functional Profiling	Factor B activity analysis can contribute to functional profiling of patient-derived samples, disease-model samples, or experimental conditions. By measuring Factor B activation and downstream pathway activity, researchers can investigate whether alternative pathway amplification is elevated, suppressed, or altered under specific conditions.
CFB Variant and Mutant Analysis	Genetic variants in complement pathway components may affect pathway regulation, convertase formation, complement amplification, or disease susceptibility. Functional testing is important for understanding whether a CFB variant alters Factor B activity, binding, cleavage, convertase stability, or regulatory sensitivity.
Biomarker and Translational Research	Factor B-related activation products such as Bb and Ba are commonly used as indicators of alternative pathway activation. These biomarkers can be measured in research samples to assess complement activation status, therapeutic response, pathway engagement, or disease-associated immune activity.
Antibody and Biologic Safety Evaluation	Some biologics may unintentionally activate complement, while others are designed to harness complement-dependent activity. Factor B-dependent amplification can influence the magnitude of complement activation triggered by antibodies, immune complexes, nanoparticles, viral vectors, cell therapies, or other biological materials.
Cell Surface Complement Regulation Studies	The activity of factor B-dependent amplification is strongly influenced by the target surface. Cell-surface complement regulators, membrane composition, antigen density, antibody orientation, and local availability of C3b can all affect alternative pathway amplification. Creative Biolabs can help evaluate how target cells, disease-associated cells, engineered cells, or therapeutic antibodies influence factor B-dependent complement activity.

Design Your Customization

Case Studies

Case 1

Measurements of circulating complement factors in HF patients

FB levels were quantified by ELISA using plasma diluted 1:400. The coating monoclonal antibody recognizes the common epitope on both the native FB and the activated Ba fragment, and it does not distinguish between active and inactive fragments. As a result, this assay only reflects the total amount of FB that is present.

FB levels were quantified by ELISA. (OA Literature) Fig. 2 Alternative complement pathway components Factor B and C3bBbP.^1,2

References

Holt, Margrethe Flesvig, et al. "The alternative complement pathway is activated without a corresponding terminal pathway activation in patients with heart failure." Frontiers in immunology 12 (2021): 800978. https://doi.org/10.3389/fimmu.2021.800978
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"Our samples came from a disease model with limited available volume, and we needed to prioritize the most informative readouts. Creative Biolabs helped us select a practical assay panel focused on Factor B activation and downstream alternative pathway biomarkers. The study was efficient, and the results provided a useful functional comparison across sample groups."

— Academic Collaborator, Complement Biology Research Center

"Our candidate appeared to reduce alternative pathway activity in serum, but we needed to know whether it affected Factor B binding, cleavage, or convertase function. Creative Biolabs developed a purified-component assay system that allowed us to focus on the C3b-Factor B-Factor D axis. The data gave us a clearer view of the mechanism and helped guide additional engineering work."

— Research Scientist, Protein Engineering Team

"We were evaluating a biologic designed to regulate alternative pathway activation. Creative Biolabs performed a series of Factor B-related assays, including Bb generation, C3b deposition, and terminal pathway marker analysis. The results helped us understand the dose-dependent effect of our molecule and provided useful information for our preclinical study design."

— Director of Preclinical Development, Biotechnology Company

"Our project required more than a standard kit-based measurement. We needed to compare serum-based alternative pathway activity across multiple treatment conditions and understand the contribution of Factor B-dependent amplification. Creative Biolabs proposed a workflow that included appropriate pathway controls, serum dilution optimization, and multiple complement activation endpoints. The final data package was well organized and easy to interpret."

— Principal Investigator, Translational Immunology Laboratory

Frequently Asked Questions

When should I choose a functional factor B assay instead of a standard ELISA?

A standard ELISA may be suitable when the goal is to quantify total Factor B, Bb, or Ba. A functional Factor B activity assay is more appropriate when the goal is to understand whether Factor B contributes to alternative pathway activation, whether an inhibitor blocks pathway function, whether a sample has altered complement activity, or whether a candidate molecule affects convertase formation or downstream complement output.

Can Creative Biolabs evaluate factor B inhibitors?

Yes. Creative Biolabs can design customized assays to evaluate Factor B inhibitors, including antibodies, antibody fragments, peptides, small molecules, aptamers, fusion proteins, recombinant regulators, or other therapeutic candidates. Assay readouts may include Bb generation, C3 convertase activity, C3 cleavage, C3b deposition, hemolysis, and downstream complement activation markers.

What is the difference between Bb and Ba detection?

Bb and Ba are both generated when Factor B is cleaved by Factor D. Bb remains associated with C3b and forms the catalytic component of the alternative pathway C3 convertase, while Ba is released into solution. Bb detection is commonly used as a marker of Factor B activation and alternative pathway convertase formation. Ba detection can provide complementary information about Factor B cleavage and may be useful in biomarker studies.

Can factor H or other complement regulators be evaluated together with factor B?

Yes. Factor H, factor I, decay-accelerating factor, membrane cofactor protein, CD55, CD46, CD59, or other complement regulators may be incorporated into customized assay designs when the goal is to understand regulatory effects on Factor B-dependent amplification or convertase stability.

Can the assay be performed in a cell-based format?

Yes. Cell-based factor B-dependent complement assays can be developed to assess complement deposition, C3b or iC3b formation, Bb deposition, C5b-9 assembly, complement-dependent cytotoxicity, or protection by complement inhibitors on target cells. This format is especially useful when surface biology, antibody binding, or disease-relevant cell context is important.

How much sample is required?

Sample volume depends on the assay format, number of readouts, number of replicates, dilution requirement, and whether optimization is included. Serum-based multi-readout studies usually require more material than single-endpoint assays. Creative Biolabs can estimate sample requirements after reviewing your project design.